About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CSE v. Epidural for Postpartum Depression

NCT03022526·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Grace Lim, MD, MS

Age

18–50

Sex

FEMALE

Healthy volunteers

Accepted

You may be eligible if

Nulliparous (no prior childbirth)
Singleton gestation
Third trimester
Healthy pregnancy
English proficiency (surveys validated in English)
Planned vaginal delivery
Planning to use labor epidural analgesia
Term delivery (\>/= 37.0 weeks)

You may not be if

Severe maternal disease
Severe fetal disease
Delivery not at term (delivery prior to 37.0 weeks)
Contraindications to neuraxial anesthesia known at the time of enrollment
Cesarean delivery WITHOUT labor
Planning to list infant for adoption
Did not receive epidural analgesia (either CSE or E) for labor

The record

StatusCompleted

PhaseNo phase

Taking part61

StartedJan 2017

UpdatedAug 19, 2020

Conditions

Depression, Postpartum Labor Pain

Where1

Magee Womens Hospital of UPMC
Pittsburgh, Pennsylvania, United States

Clareo Health | CSE v. Epidural for Postpartum Depression